Moreover, cerebral levels of insulin and insulin receptor (IR) are lower in the brain of AD patients, and evidence for insulin signaling impairment in post-mortem brain tissue of AD patients and in animal models of AD has been shown (Steen et al., 2005; Chiu et al., 2008; Talbot et al., 2012). The gene discussed is INSR; the disease is Alzheimer disease.